5-33988023-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014324.6(AMACR):​c.*1070C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.031 in 248,714 control chromosomes in the GnomAD database, including 387 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 224 hom., cov: 33)
Exomes 𝑓: 0.024 ( 163 hom. )

Consequence

AMACR
NM_014324.6 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.583
Variant links:
Genes affected
AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
C1QTNF3-AMACR (HGNC:49198): (C1QTNF3-AMACR readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C1q and tumor necrosis factor related protein 3 (C1QTNF3) and alpha-methylacyl-CoA racemase (AMACR) genes on chromosome 5. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus not likely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 5-33988023-G-A is Benign according to our data. Variant chr5-33988023-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 353238.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.156 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMACRNM_014324.6 linkc.*1070C>T 3_prime_UTR_variant Exon 5 of 5 ENST00000335606.11 NP_055139.4 Q9UHK6-1
AMACRNM_001167595.2 linkc.*285C>T 3_prime_UTR_variant Exon 6 of 6 NP_001161067.1 Q9UHK6-5
AMACRNM_203382.3 linkc.*1461C>T 3_prime_UTR_variant Exon 4 of 4 NP_976316.1 Q9UHK6-4
C1QTNF3-AMACRNR_037951.1 linkn.2575C>T non_coding_transcript_exon_variant Exon 9 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMACRENST00000335606.11 linkc.*1070C>T 3_prime_UTR_variant Exon 5 of 5 1 NM_014324.6 ENSP00000334424.6 Q9UHK6-1
C1QTNF3-AMACRENST00000382079.3 linkn.*1645C>T non_coding_transcript_exon_variant Exon 9 of 9 2 ENSP00000371511.3 E9PGA6
C1QTNF3-AMACRENST00000382079.3 linkn.*1645C>T 3_prime_UTR_variant Exon 9 of 9 2 ENSP00000371511.3 E9PGA6

Frequencies

GnomAD3 genomes
AF:
0.0355
AC:
5393
AN:
152096
Hom.:
223
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0749
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0446
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.166
Gnomad SAS
AF:
0.0523
Gnomad FIN
AF:
0.0171
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00357
Gnomad OTH
AF:
0.0325
GnomAD4 exome
AF:
0.0240
AC:
2314
AN:
96500
Hom.:
163
Cov.:
0
AF XY:
0.0223
AC XY:
1090
AN XY:
48972
show subpopulations
African (AFR)
AF:
0.0717
AC:
252
AN:
3516
American (AMR)
AF:
0.0482
AC:
141
AN:
2924
Ashkenazi Jewish (ASJ)
AF:
0.00274
AC:
11
AN:
4014
East Asian (EAS)
AF:
0.162
AC:
1364
AN:
8394
South Asian (SAS)
AF:
0.0514
AC:
55
AN:
1070
European-Finnish (FIN)
AF:
0.0125
AC:
70
AN:
5620
Middle Eastern (MID)
AF:
0.0162
AC:
9
AN:
556
European-Non Finnish (NFE)
AF:
0.00344
AC:
219
AN:
63682
Other (OTH)
AF:
0.0287
AC:
193
AN:
6724
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
94
188
282
376
470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0355
AC:
5408
AN:
152214
Hom.:
224
Cov.:
33
AF XY:
0.0375
AC XY:
2787
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0749
AC:
3112
AN:
41526
American (AMR)
AF:
0.0449
AC:
686
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3470
East Asian (EAS)
AF:
0.165
AC:
852
AN:
5160
South Asian (SAS)
AF:
0.0519
AC:
250
AN:
4818
European-Finnish (FIN)
AF:
0.0171
AC:
181
AN:
10614
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00357
AC:
243
AN:
68022
Other (OTH)
AF:
0.0350
AC:
74
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
240
481
721
962
1202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0279
Hom.:
120
Bravo
AF:
0.0397
Asia WGS
AF:
0.109
AC:
376
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oculocutaneous albinism Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Alpha-methylacyl-CoA racemase deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
4.5
DANN
Benign
0.72
PhyloP100
0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs16892064; hg19: chr5-33988128; API